CYP2D6 Genetic Characteristics in Recurrent Plasmodium vivax Malaria Cases in the Republic of Korea
Plasmodium vivax malaria remains an important public health concern in the Republic of Korea, which targets elimination by 2030. Primaquine is essential for radical cure and relapse prevention; its metabolic activation involves cytochrome P450 2D6 (CYP2D6). CYP2D6 genetic variation may influence metabolic capacity and contribute to primaquine treatment response differences. We examined CYP2D6 genotype and predicted metabolizer phenotype distributions among Korean patients with P. vivax malaria, exploring their associations with recurrence. We analyzed 106 P. vivax specimens collected by the Korea Disease Control and Prevention Agency during 2016–2026. Activity scores and predicted metabolizer phenotypes were derived from genotypes. Allele and phenotype frequencies were compared using Fisher’s exact test; activity scores were compared using the Mann–Whitney U test. Compared with the non-recurrence group, the recurrence group had a significantly higher *10B allele frequency (p = 0.002) and proportion of intermediate metabolizers (p = 0.029), and a significantly lower *1 allele frequency (p = 0.001) and activity score (p = 0.026). The reduced-function *10B allele and intermediate metabolizer phenotype were common in Korean patients with P. vivax malaria. Reduced predicted CYP2D6 metabolic capacity may be associated with recurrence, supporting prospective evaluation of CYP2D6 variation and primaquine treatment response.
Authors
- Bora Ku
- Haneul Jung (ORCID: https://orcid.org/0009-0009-6443-6456)
- Seon-Young Lee (ORCID: https://orcid.org/0000-0002-2734-3594)
- Sang-Eun Lee (ORCID: https://orcid.org/0000-0002-2114-579X)
- Il‐Hwan Kim (ORCID: https://orcid.org/0000-0003-3566-5523)
Institutions
- Korea Disease Control and Prevention Agency (KR)
Publication Details
- Journal
- Tropical Medicine and Infectious Disease
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3390/tropicalmed11110332
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Korea Disease Control and Prevention Agency